BlackRock Group’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-239
Closed -$435K 2894
2014
Q2
$435K Hold
239
﹤0.01% 2252
2014
Q1
$388K Sell
239
-146
-38% -$305K ﹤0.01% 2314
2013
Q4
$496K Hold
385
﹤0.01% 2233
2013
Q3
$773K Buy
+385
New +$716K ﹤0.01% 2054

Other funds holding HSTO

BlackRock Group's HSTO Position: Q3 2014 in Review

BlackRock Group sold out of Histogen Inc. Common Stock (HSTO) in Q3 2014, closing a stake of 239 shares — an estimated $435K sold.

BlackRock Group first reported a position in HSTO in Q3 2013 and held it in 4 quarters. The position peaked at $773K in Q3 2013. 34 funds tracked by Wall St. Rank hold HSTO as of Q3 2014.

  • BlackRock Group reported no remaining Histogen Inc. Common Stock position as of Q3 2014 after selling out during the quarter.
  • BlackRock Group sold 239 Histogen Inc. Common Stock shares in Q3 2014, an estimated $435K.
  • BlackRock Group first reported a position in Histogen Inc. Common Stock in Q3 2013 and held it in 4 quarters.
  • BlackRock Group's Histogen Inc. Common Stock position peaked at $773K in Q3 2013.
  • 34 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q3 2014.

Based on BlackRock Group's 13F filing for Q3 2014, filed 29 Oct 2014.